GMXRX
Price
$15.76
Change
+$0.10 (+0.64%)
Updated
Jul 3 closing price
Net Assets
540.35M
VMCPX
Price
$383.04
Change
+$2.26 (+0.59%)
Updated
Jul 3 closing price
Net Assets
185.28B
Interact to see
Advertisement

GMXRX vs VMCPX

Header iconGMXRX vs VMCPX Comparison
Open Charts GMXRX vs VMCPXBanner chart's image
Nationwide Mid Cap Market Idx R
Price$15.76
Change+$0.10 (+0.64%)
VolumeN/A
Net Assets540.35M
Vanguard Mid Cap Index InstitutionalPlus
Price$383.04
Change+$2.26 (+0.59%)
VolumeN/A
Net Assets185.28B
GMXRX vs VMCPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GMXRX vs. VMCPX commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMXRX is a Buy and VMCPX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMCPX has more cash in the bank: 185B vs. GMXRX (540M). VMCPX pays higher dividends than GMXRX: VMCPX (1.54) vs GMXRX (0.77). GMXRX was incepted earlier than VMCPX: GMXRX (18 years) vs VMCPX (15 years). GMXRX (1.01) is less costly to investors than VMCPX (0.03). GMXRX is a more actively managed with annual turnover of: 17.74 vs. VMCPX (16.00). GMXRX has a lower initial minimum investment than VMCPX: GMXRX (0) vs VMCPX (100000000). VMCPX annual gain was more profitable for investors over the last year : 16.95 vs. GMXRX (-1.64). VMCPX return over 5 years is better than : 72.78 vs. GMXRX (24.39).
GMXRXVMCPXGMXRX / VMCPX
Total Expense Ratio1.000.033,333%
Annual Report Gross Expense Ratio1.010.033,367%
Fund Existence18 years15 years-
Gain YTD1.8956.99627%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets540M185B0%
Annual Yield % from dividends0.771.5450%
Returns for 1 year-1.6416.95-10%
Returns for 3 years10.0542.2924%
Returns for 5 years24.3972.7834%
Returns for 10 years-13.19126.27-10%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NUS8.920.10
+1.13%
NuSkin Enterprises
FATE1.12N/A
N/A
Fate Therapeutics
RIOT12.17-0.03
-0.25%
Riot Platforms
UMC7.83-0.03
-0.38%
United Microelectronic Corp
BGLC6.43-0.39
-5.72%
Bionexus Gene Lab Corp